Methotrexate Vial How Supplied/Storage and Handling

()

16 HOW SUPPLIED/STORAGE AND HANDLING

How Supplied

Methotrexate Injection is a clear, yellow, sterile solution available with preservative (multiple-dose vials) and preservative-free (single-dose vials) as follows:

Strength/Fill volumeNDC numberPack style

With Preservative

50 mg/2 mL (25 mg/mL)

61703-350-38

Carton containing five (5) multiple-dose vials

Preservative-free

1 g/40 mL (25 mg/mL)

61703-408-41

Carton containing one (1) single-dose vial

Carton contentsNDC

Methotrexate Injection, With Preservative, 5 multiple-dose vials

50 mg/2 mL (25 mg/mL)

61703-350-38

Preservative-free Methotrexate Injection, 1 single-dose vial

1 g/40 mL (25 mg/mL)

61703-408-41

Storage and Handling

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light.

After first puncture, store multiple-dose vials at 2°C to 8°C, and use within 30 days.

Methotrexate Injection is a hazardous drug. Follow applicable special handling and disposal procedures.1

Find Methotrexate Vial medical information:

Find Methotrexate Vial medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

Methotrexate Vial Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

How Supplied

Methotrexate Injection is a clear, yellow, sterile solution available with preservative (multiple-dose vials) and preservative-free (single-dose vials) as follows:

Strength/Fill volumeNDC numberPack style

With Preservative

50 mg/2 mL (25 mg/mL)

61703-350-38

Carton containing five (5) multiple-dose vials

Preservative-free

1 g/40 mL (25 mg/mL)

61703-408-41

Carton containing one (1) single-dose vial

Carton contentsNDC

Methotrexate Injection, With Preservative, 5 multiple-dose vials

50 mg/2 mL (25 mg/mL)

61703-350-38

Preservative-free Methotrexate Injection, 1 single-dose vial

1 g/40 mL (25 mg/mL)

61703-408-41

Storage and Handling

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light.

After first puncture, store multiple-dose vials at 2°C to 8°C, and use within 30 days.

Methotrexate Injection is a hazardous drug. Follow applicable special handling and disposal procedures.1

Medication Guide

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.